Among the four types of FGFRs (FGFR1–4), high expression of FGFR1 but not of FGFR2–4 correlates with reduced survival of GBM patients, and FGFR1 expression is increased in GBM compared to normal brain tissue [5,6]. This evidence concerns the gene FGFR1 and glioblastoma.